Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: BostonView who wrote (886)	4/13/2000 3:50:00 PM
From: Ian@SI	Read Replies (1) \| Respond to of 1321

BV, There are 250 US sites with Visudyne, lasers and trained doctors; all of them with a long list of patients urgently requiring treatment. In addition to the 200,000 new cases annually, there's still about 1M patients with the condition that have not yet lost all their eyesight yet; and who are increasingly desparate to save whatever remaining vision they still have. I expect QLT to significantly blow away analysts' forecasts. And this should be very good. FWIW, Ian. P.S. Now close to up 2 3/4 for the day. Looks like we'll close somewhere between 59 and 60.